Insurance, Coupon Programs, and Out-of-Pocket Optimization Many insurance plans now cover GLP-1 medications for weight management and diabetes, but prior authorization requirements and step-therapy protocols can delay access
Where things stand: Eli Lilly is conducting multiple Phase 3 trials (the TRIUMPH program) with over 5,800 participants enrolled
According to the FDA, outsourcing facilities that comply under section 503B are not required to receive FDA approval of their compounded drug products
Aschner M, Aschner JL (1990) Mercury neurotoxicity: mechanisms of blood-brain barrier transport
The comparison between orforglipron and injectable GLP-1 medications touches on efficacy, convenience, side effects, cost, and long-term access